Abstract
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID). It exists as two enantiomers (R and S ibuprofen) but only the S form is considered to have the many activities of this class of drug, effects such as analgesic, anti-inflammatory, anti-pyretic and anti-platelet actions. These pharmacological properties have been related to inhibition of prostaglandin H synthase although there is still doubt that all the pharmacological activities of this or other NSAIDs are the result only of inhibition of the synthesis of prostanoids.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Williams KM. Molecular asymmetry and its pharmacological consequences. Adv Pharmacol. 1991;2:57–135.
Kelley MT, Walson PD, Edge JH, Cox S, Mortensen ME. Pharmacokinetics and pharmacodynamics of ibuprofen and acetaminophen in febrile children. Clin Pharmacol Ther. 1992;52:181–9.
Menzel S, Waibel R, Brune K, Geisslinger G. Is the formation of R-ibuprofenyl-adenylate the first stereoselective step of chiral inversion? Biochem Pharmacol. 1994;48:1056–8.
Williams KM, Day R, Knihinicki R, Duffield A. The stereoselective uptake of ibuprofen enantiomers into adipose tissue. Biochem Pharmacol. 1986;35:3403–5.
Williams KM, Nelson CJ, Lohrer F, Ellis B, Tattum B, Day RO. Ibuprofen cholesterol esters. J Clin Pharmacol. 1995;35:939.
Ellis BA, Nelson C, Day RO, Williams KM. Characterization of non-steroidal anti-inflammatory drug (NSAID) thioesters as inhibitors of carnitine palmitoyl transferase in rat liver. Proc ASCEPT. 1996;3:131.
Zhao B, Geisslinger G, Hall I, Day RO, Williams KM. The effect of the enantiomers of ibuprofen and flurbiprofen on the β-oxidation of palmitate in the rat. Chirality. 1992;4:137–41.
Williams KM, Browne G, Nelson CJ, Nguyen T, Day RO. Effects of 2-arylpropionic acids on the β- oxidation of fatty acids. J Clin Pharmacol. 1995;35:938.
Freneaux E, Fromenty B, Berson A et al. Stereoselective and non-selective effects of ibuprofen enantiomers on mitochondrial β-oxidation of fatty acids. J Pharmacol Exp Ther. 1990;255:529–35.
Evans AM, Nation RL, Sansom LN. Lack of effect of cimetidine on the pharmacokinetics of R(-) and S(+)-ibuprofen. Br J Clin Pharmacol. 1989;28:143–9.
Evans AM, Pharmacodynamics and pharmacokinetics of the profens: Enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen. J Clin Pharmacol. 1996;36:7S–15S.
Scheuerer S, Oelkers R, Brune K, Williams KM, Geisslinger G. Effect of clofibrate on the chiral inversion of ibuprofen in healthy volunteers. Naunyn-Schmiedebergs Arch Pharamcol. 1996;353(Suppl):R 147.
Avgerinos A, Hutt AJ. Interindividual variability in the enantiomeric disposition of ibuprofen following the oral administration of the racemic drug to healthy volunteers. Chiralty. 1990;2:249–56.
Smith DE, Paliwal JK, Cox SR, Berardi RR, Dunn-Kucharski VA, Elta GH. The effect of competitive and non-linear plasma protein binding on the stereoselective disposition and metabolite inversion of ibuprofen in healthy subjects. Biopharm Drug Dispos. 1994;15:545–61.
Li G, Treiber G, Maier K, Walker S, Klotz U. Disposition of ibuprofen in patients with liver cirrhosis. Stereochemical considerations. Clin Pharmacokinet. 1993;25:154–63.
Evans AM, Nation RL, Sansom LN, Bochner F, Somogyi AA. The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans. Biopharm Drug Dispos. 1990;11:507–18.
Paliwal JK, Smith DE, Cox SR, Berardi RR, Dunn-Kucharski VA, Elta GH. Stereoselective, competitive and nonlinear plasma protein binding of ibuprofen enantiomers as determined in vivo in healthy subjects. J Pharmacokinet Biopharm. 1993;21:145–61.
Villanueva M, Heckenberger R, Strobach H, Palmér M, Schrör K. Equipotent inhibition by R(-), S(+)-and racemic ibuprofen of human polymorphonuclear cell function in vitro. Br J Clin Pharmacol. 1993;35:235–42.
Graham GG, Tsui D, Torda TA. A simplified approach to the effect kinetics of atracurium. Br J Anaesth. 1990;64:28–32.
Day RO, Williams KM, Graham GG, Lee EJ, Knihinicki RD, Champion GD. Stereoselective disposition of ibuprofen enantiomers in synovial fluid. Clin Pharmacol Ther. 1988;43:480–7.
Seideman P, Lohrer F, Graham GG, Duncan MW, Williams KM, Day RO. The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid. Br J Clin Pharmacol. 1994;38:221–7.
Blaser J, Rieder HI, Luthy R. Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters. Antimicrob Agents Chemother. 1991;35:837–9.
Lötsch J, Geisslinger G, Mohammadian P, Brune K, Kobal G. Effects of flurbiprofen enantiomers on pain-related chematosensory evoked potentials in human subjects. Br J Clin Pharmacol. 1995;40:33946.
Oelkers R, Neupert W, Williams KM, Brune K, Geisslinger G. Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid. Br J Clin Pharmacol. 1997;43:145–53.
Wechter WJ, McCracken JD, Kantoci D et al. Enhancement of ulcer formation and antiproliferative effects of R-flurbiprofen. Presented at Inflammopharmacology Symposium, San Francisco, CA, March 1997.
McCracken JD, Liu Y, Chase RL et al. Antiproliferative effects of the enantiomers of flurbiprofen. J Clin Pharmacol. 1996;36:540–5.
Giannakopoulos B, Perry MA, Williams KM, Antoon JS. Intestinal injury caused by S, R and RSflurbiprofen under conditions of altered osmolality. Proc ASCEPT. 1996;3:64.
Prescott LF, Speirs GC, Critchley JAJH, Temple RM, Winney RJ. Paracetamol disposition and metabolite kinetics in patients with chronic renal failure. Eur J Clin Pharmacol. 1989;36:291–7.
Baraka OZ, Truman CA, Ford JM, Roberts CJC. The effect of propranolol on paracetamol metabolism in man. Br J Clin Pharmacol. 1990;29:261–4.
Bannwarth B, Netter P, Lapicque F et al. Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmacol. 1992;34:79–81.
Moreau X, Le Quay L, Granry JC, Boishardy N, Delhumeau A. Pharmacokinetics of paracetamol in the cerebrospinal fluid in the elderly. Therapie. 1993;48:393–6.
Brown RD, Wilson JT, Kearns GL, Eichler VF, Johnson VA, Bertrand KM. Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children J Clin Pharmacol. 1992;32:231–41.
Piletta P, Porchet HC, Dayer P. Central analgesic effect of acetaminophen but not of aspirin. Clin Pharmacol Ther. 1991;49:350–4.
Seymour RA, Rawlins MD. Pharmacokinetics of parenteral paracetamol and its analgesic effects in post-operative dental pain. Eur J Clin Pharmacol. 1981;20:215–8.
Flinn FB, Brodie BB. The effect on the pain threshold of N-acetyl p-aminophenol, a product derived in the body from acetanilide. J Pharmacol Exp Ther. 1948;94:76–7.
Nelson E, Morioka T. Kinetics of the metabolism of acetaminophen by humans. J Pharm Sci. 1963;52:864–8.
Quiding H, Oikarinen V, Sane J, Sjöblad A-M. Analgesic efficacy after single and repeated doses of codeine and acetaminophen. J Clin Pharmacol. 1984;24:27–34.
Levy G. Pharmacokinetic analysis of the analgesic effect of a second dose of acetaminophen in humans. J Pharm Sci. 1987;76:88–9.
Cooper SA, Schachtel BP, Goldman E, Gelb S, Cohn P. Ibuprofen and acetaminophen in the relief of acute pain: A randomized, double-blind, placebo-controlled study. J Clin Pharmacol. 1989;29:1026–30.
Owen SG, Francis HW, Roberts MS. Disappearance kinetics of solutes from synovial fluid after infra-articular injection. Br J Clin Pharmacol. 1994;38:349–55.
Marquez LA, Dunford HB. Interaction of acetaminophen with myeloperoxidase intermediates: optimum stimulation of enzyme activity. Arch Biochem Biophys. 1993;305:414–20.
van Zyl JM, Basson K, van der Walt B. The inhibitory effect of acetaminophen on the myeloperoxidaseinduced antimicrobial system of the polymorphonuclear leukocyte. Biochem Pharmacol. 1989;38:1615.
Shalabi EA. Acetaminophen inhibits the human polymorphonuclear function in vitro. Immunopharmacology. 1992;24:37–46.
Milligan MK, Newsham DW, Nguyen L, Spicer F, Graham GG, Ziegler JB. Metabolism of paracetamol and inhibition of hypochlorous acid formation by neutrophils. Proc ASCEPT. 1996;3:65.
O’Brien PJ, Khan S, Jatoe SD. Formation of biological reactive intermediates by peroxidases: halide mediated acetaminophen oxidation and cytotoxicity. Adv Exp Med Biol. 1990;283:51–64.
Seideman PJ. Additive effect of combined naproxen and paracetamol in rheumatoid arthritis. Br J R heumatol. 1993;32:1077–82.
Corbett MD, Corbett BR, Hannothiaux M-H, Quintana SJ. Metabolic activation and nucleic acid binding of acetaminophen and related arylamine substrates by the respiratory burst of human granulocytes. Chem Res Toxicol. 1989;2:260–6.
Mason RP, Fisher V. Possible role of free radical formation in drug-induced agranulocytosis. Drug Safety. 1992;7(suppl 1):45–50.
Potter DW, Hinson JA. The 1- and 2-electron oxidation of acetaminophen catalyzed by prostaglandin H synthase. J Biol Chem. 1987;262:974–80.
Harvison PJ, Egan RW, Gale PH, Nelson SD. Acetaminophen as a cosubstrate and inhibitor of prostaglandin H synthase. Adv Exp Med Biol. 1985;197:739–47.
Lands WEM, Cook HW, Rome LH. Prostaglandin biosynthesis; the consequences of oxygenase mechanism upon in vitro assays of drug effectiveness. Adv Prostagland Thrombox Res. 1976;1:7–17.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Graham, G.G., Milligan, M.K., Day, R.O., Williams, K.M., Ziegler, J.B. (1998). Therapeutic Considerations from Pharmacokinetics and Metabolism: Ibuprofen and Paracetamol. In: Rainsford, K.D., Powanda, M.C. (eds) Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4878-8_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-4878-8_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6044-8
Online ISBN: 978-94-011-4878-8
eBook Packages: Springer Book Archive